A detailed history of Quantinno Capital Management LP transactions in Bio Techne Corp stock. As of the latest transaction made, Quantinno Capital Management LP holds 66,484 shares of TECH stock, worth $4.86 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
66,484
Previous 66,088 0.6%
Holding current value
$4.86 Million
Previous $4.74 Million 12.19%
% of portfolio
0.07%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$70.96 - $82.35 $28,100 - $32,610
396 Added 0.6%
66,484 $5.31 Million
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $2.92 Million - $3.96 Million
47,080 Added 247.69%
66,088 $4.74 Million
Q1 2024

May 14, 2024

BUY
$65.98 - $77.09 $35,365 - $41,320
536 Added 2.9%
19,008 $1.34 Million
Q4 2023

Feb 14, 2024

SELL
$52.83 - $78.22 $332,406 - $492,160
-6,292 Reduced 25.41%
18,472 $1.43 Million
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $594,378 - $787,164
8,803 Added 55.15%
24,764 $1.69 Million
Q2 2023

Aug 04, 2023

BUY
$73.76 - $85.98 $23,824 - $27,771
323 Added 2.07%
15,961 $1.3 Million
Q1 2023

May 03, 2023

SELL
$71.62 - $86.62 $265,280 - $320,840
-3,704 Reduced 19.15%
15,638 $1.16 Million
Q4 2022

Feb 13, 2023

BUY
$80.67 - $352.29 $1.31 Million - $5.73 Million
16,252 Added 525.95%
19,342 $1.6 Million
Q3 2022

Nov 07, 2022

SELL
$282.54 - $391.85 $482,578 - $669,279
-1,708 Reduced 35.6%
3,090 $878,000
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $329,768 - $459,542
1,022 Added 27.07%
4,798 $1.66 Million
Q1 2022

May 12, 2022

BUY
$353.85 - $487.79 $242,741 - $334,623
686 Added 22.2%
3,776 $1.64 Million
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $1.41 Million - $1.62 Million
3,090 New
3,090 $1.6 Million
Q1 2021

May 17, 2021

SELL
$314.62 - $411.0 $289,450 - $378,120
-920 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$246.9 - $321.87 $227,148 - $296,120
920 New
920 $292,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.86B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Quantinno Capital Management LP Portfolio

Follow Quantinno Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.